ProfileGDS5822 / ILMN_2641438
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 67% 70% 69% 71% 68% 70% 74% 67% 64% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 139.467
GSM1276600PDAC Late Ablation Control 255.670
GSM1276601PDAC Late Ablation Control 368.469
GSM1276602PDAC Late Ablation 155.171
GSM1276603PDAC Late Ablation 247.168
GSM1276604PDAC Late Ablation 358.170
GSM1303940PDAC Late Ablation_anti-CTLA4 170.474
GSM1303941PDAC Late Ablation_anti-CTLA4 253.667
GSM1303942PDAC Late Ablation_anti-CTLA4 34764